Ceramella, J.; Rosano, C.; Iacopetta, D.; Ben Toumia, I.; Chekir-Ghedira, L.; Maatouk, M.; Mariconda, A.; Longo, P.; Dallemagne, P.; Rochais, C.;
et al. Anti-Breast Cancer Properties and In Vivo Safety Profile of a Bis-Carbazole Derivative. Pharmaceutics 2025, 17, 415.
https://doi.org/10.3390/pharmaceutics17040415
AMA Style
Ceramella J, Rosano C, Iacopetta D, Ben Toumia I, Chekir-Ghedira L, Maatouk M, Mariconda A, Longo P, Dallemagne P, Rochais C,
et al. Anti-Breast Cancer Properties and In Vivo Safety Profile of a Bis-Carbazole Derivative. Pharmaceutics. 2025; 17(4):415.
https://doi.org/10.3390/pharmaceutics17040415
Chicago/Turabian Style
Ceramella, Jessica, Camillo Rosano, Domenico Iacopetta, Iméne Ben Toumia, Leila Chekir-Ghedira, Mouna Maatouk, Annaluisa Mariconda, Pasquale Longo, Patrick Dallemagne, Christophe Rochais,
and et al. 2025. "Anti-Breast Cancer Properties and In Vivo Safety Profile of a Bis-Carbazole Derivative" Pharmaceutics 17, no. 4: 415.
https://doi.org/10.3390/pharmaceutics17040415
APA Style
Ceramella, J., Rosano, C., Iacopetta, D., Ben Toumia, I., Chekir-Ghedira, L., Maatouk, M., Mariconda, A., Longo, P., Dallemagne, P., Rochais, C., & Sinicropi, M. S.
(2025). Anti-Breast Cancer Properties and In Vivo Safety Profile of a Bis-Carbazole Derivative. Pharmaceutics, 17(4), 415.
https://doi.org/10.3390/pharmaceutics17040415
